Language selection

Government of Canada / Gouvernement du Canada

Search

Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age.: HP5-144/1-2022E-PDF ; HP5-144/2-2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.916203&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleRecommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Recommandations sur l'utilisation du vaccin Comirnaty (3 mcg) de Pfizer-BioNTech contre la COVID-19 chez les enfants de 6 mois à 4 ans.
  • On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
  • "Pub.: 220481."
  • "Pub.: 220483."
  • Includes bibliographical references (pages 21-23).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, October 21, 2022.
  • ©2022
Description1 online resource (27 pages) + summary (6 pages)
ISBN9780660458274 9780660458281
Catalogue number
  • HP5-144/1-2022E-PDF
  • HP5-144/2-2022E-PDF
Departmental catalogue number220481 220483
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: